Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on January 3, 2019. The report announces the consolidated financial results for the second quarter of fiscal year 2019. The filing serves to furnish a press release (Exhibit 99.1) containing these results.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no specific financial metrics are available in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the second quarter of fiscal year 2019 have been announced.
Guidance, Outlook, and Risks
The text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the report and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant is Landec Corporation, not Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (the press release dated January 3, 2019) for actual financial figures, as they are absent from this cover document.
- Confirm the reporting period is the second quarter of fiscal year 2019.
- Note that this specific 8-K text is not subject to Section 18 liabilities of the Exchange Act.